Research trends and global productivity on mechanical ventilation with the impact of COVID-19: a bibliometric analysis in the period 1980-2021

Abstract

Aim: Although the number of global studies on mechanical ventilation (MV) therapy, which plays an important role in the life process of patients in the intensive care unit, has increased, there is still no bibliometric research on this subject in the literature. This study, it was aimed to determine trend topics and global productivity by holistically analyzing scientific articles on MV published between 1980 and 2021 using various statistical methods and bibliometric approaches. 
 Material and Method: Articles on MV published between 1980 and 2021 were downloaded from the Web of Science (WoS) database and analyzed using various statistical methods. Spearman's correlation coefficient was used for correlation studies. Network visualization maps were used to identify the most effective studies with global collaborations, trend topics, and citation analysis.
 Results: The study, which was in the category of 5323 articles out of a total of 10135 publications, was analyzed. The first 3 countries that contributed the most to the literature were the USA (n=1740), France (448), and Canada (386). The most active author was Laurent Brochard (n=50). The top 3 most active institutions were Assistance Publique Hopitaux Paris (224), University of Toronto (216), and League of European Research Universities (169). The top 3 journals that published the most articles were Critical Care Medicine (289), Chest (204), and Intensive Care Medicine (166). Gross Domestic Product (GDP) was highly effective in article productivity (r=0.719, p

The effects of body mass index on postoperative pain in patients undergoing thoracic paravertebral block after video-assisted thoracoscopic surgery: A retrospective analysis

“…Here, it may be necessary to provide patients with invasive mechanical ventilator support again. This may cause additional complications, such as ventilator-associated pneumonia, barotrauma, and volutrauma in patients (24). Therefore, providing analgesia with adequate doses of agents is especially important in thoracic surgery.…”

Comparison of clinical outcomes of intensive care patients with COVID-19 pneumonia receiving and not receiving tocilizumab treatment

“…Coronavirus disease 2019 (COVID- 19) is an infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with high morbidity and mortality and impairing quality of life (1,2). The first case of pneumonia due to COVID-19 emerged in December 2019 in Wuhan city of China's Hubei province (3).…”

The progress of chronic renal disease patients followed by the diagnosis of COVID-19 in ICU

“…Coronavirus disease 2019 (COVID-19) disease started in December 2019 in Wuhan, China. Then, it spread all over the world and was declared a pandemic by the World Health Organization (WHO) as of March 2020 (1)(2)(3). One of the targets of COVID-19, which affects many systems, is the kidneys.…”